Monogram Orthopedics Partners with India's Shalby Limited for Clinical Trials of Advanced Surgical Robot

Monogram Orthopedics (NASDAQ: MGRM) has announced a strategic partnership with Shalby Limited (NSE: SHALBY), one of India's leading orthopedic hospital groups, to advance its surgical robot technology. This collaboration marks a significant milestone for Monogram as it seeks to demonstrate the safety and effectiveness of its mBȏs TKA System for robotic orthopedic surgery and implants.

The partnership will involve a multicenter clinical trial campaign, leveraging Shalby's extensive network of hospitals and seasoned knee replacement surgeons. Shalby, led by renowned joint replacement surgeon Vikram I. Shah, commands 15% of India's organized arthroplasty market and is well-positioned to capitalize on India's growing population and increasing demand for orthopedic procedures.

Ben Sexson, CEO of Monogram Technologies, highlighted the massive market potential in India, citing the country's underpenetration for robotics and the large volume of knee arthroplasties performed annually. The clinical trial will provide Monogram with valuable real-world data and could pave the way for future collaborations and the integration of Monogram's robotic systems into Shalby's hospital network.

This partnership comes at a time when the global orthopedic surgery market is experiencing a resurgence, having expanded by 6.3% to $59 billion in 2023. Research indicates that nearly 6 million lives are lost annually due to traumatic injuries, many of which could be prevented with more efficient and precise surgical interventions. Monogram's technology aims to address these inefficiencies by offering advanced robotic solutions that promise better patient outcomes.

Shalby's ambitious growth plans, including international expansion and a strong presence in the U.S. market, align with Monogram's vision of revolutionizing orthopedic surgery through innovative technology. The success of this clinical trial could have far-reaching implications for the industry, potentially setting new standards for safety, precision, and effectiveness in orthopedic procedures.

As Monogram awaits regulatory approvals for its mBȏs TKA System, the company's collaboration with Shalby represents a significant step toward transforming the landscape of orthopedic surgery. The trial is expected to enroll patients across India, with surgeons assessing the success of the mBȏs TKA System alongside Shalby's Consensus Knee System implant.

With this partnership, Monogram and Shalby are poised to make substantial contributions to the field of robotic orthopedic surgery, addressing the unmet needs of a rapidly growing market and improving patient care on a global scale.